Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.15.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.273ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.13 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.358ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.159ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.6.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.141ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.591ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.468ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.131 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.586ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.366ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.380ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.100ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.43.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EU.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EK.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.66ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.299ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.149ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.300ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.179ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.125ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
G.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.438ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.120ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.249ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.505ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.406ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.115ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used